UBS Knock-Out AZN/ DE000UM9KVE7 /
9/6/2024 9:54:50 PM | Chg.+0.020 | Bid- | Ask- | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.370EUR | +5.71% | - Bid Size: - |
- Ask Size: - |
AstraZeneca PLC | 79.8155 USD | 12/31/2078 | Call |
GlobeNewswire
8/13
Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
6/20
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Gr...
GlobeNewswire
5/15
Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
5/13
Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
5/8
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire
4/1
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent ...
GlobeNewswire
3/25
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, In...
GlobeNewswire
3/25
Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
GlobeNewswire
3/19
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Phar...
GlobeNewswire
3/15
American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Agains...